StockData
Eupraxia Pharmaceuticals Inc. logo

Eupraxia Pharmaceuticals Inc. (EPRX) stock

EPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 13, 2026Score 5/30
$8.15+0.34 (+4.35%)

Close on Nov 13, 2026Market cap $491.40MP/E –Yield –

Eupraxia Pharmaceuticals statistics

60 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Dec 31, 2025
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$491.40M
$272.32M
Enterprise Value
$409.24M
$146.23M
PB Ratio
5.99
2.00
P/TBV Ratio
5.99
2.22

Share statisticsIndustry

Shares Change (YoY)
17.8%
10.8%
Float
54M
49M
Shares Held by Insiders
9.69%
11.7%
Shares Held by Institutions
41.1%
56.4%

Short sellingIndustry

Short Interest
6M
–
Short Interest Change
-4.47%
-0.80%
Short % of Float
11.5%
9.01%
Short % of Shares Outstanding
10.4%
6.30%
Days to Cover
10.36
5.15

Stock price statisticsIndustry

52-Week High
$9.32
–
52-Week Low
$5.63
–
20-Day Moving Average
$7.25
–
50-Day Moving Average
$7.64
–
200-Day Moving Average
$7.23
–
Average True Range (14)
$0.53
–
Price Change (1 Week)
18.3%
-1.15%
Price Change (1 Month)
20.4%
-4.87%
Price Change (3 Months)
19.5%
-21.0%
Price Change (6 Months)
17.8%
-20.6%
Price Change (YTD)
7.95%
-23.6%
Price Change (1 Year)
23.5%
-22.4%
Price Change (3 Years)
105.9%
-29.5%
Price Change (5 Years)
262.2%
-77.9%
Average Volume (10 Days)
567,458
–
Average Volume (20 Days)
589,288
–
Average Volume (90 Days)
587,519
–
Relative Volume
1.34
0.70
Relative Strength Index (14)
60.8
43.4
Volatility (1 Year)
65.1%
80.1%
Beta (5 Years)
-0.02
1.07

Returns on capitalIndustry

Return on Equity (ROE)
-66.8%
-49.9%
Return on Assets (ROA)
-63.7%
-40.6%

Financial positionIndustry

Current Ratio
15.12
3.30
Quick Ratio
14.44
2.39

EfficiencyIndustry

Asset Turnover
0.00
0.40
WACC
7.60%
10.2%

Income statement (TTM)Industry

Revenue
$0
$66.37M
Pretax Income
-$38.59M
-$12.95M
Net Income
-$38.58M
-$22.35M
EPS (Diluted)
-$1.03
-$0.76

Balance sheetIndustry

Net Cash (Debt)
$80.56M
$17.76M
Net Cash Per Share
$1.34
$0.80
Equity (Book Value)
$82.04M
$53.89M
Book Value Per Share
$1.36
$1.50
Tangible Book Value
$82.04M
$27.13M
Working Capital
$79.47M
$79.99M

Cash flow (TTM)Industry

Operating Cash Flow
-$28.55M
-$12.38M

Dividends and yieldsIndustry

Earnings Yield
-7.85%
-21.8%
Buyback Yield
-15.0%
-0.76%
Shareholder Yield
-15.0%
0.00%

Taxes and interestIndustry

Interest Expense
$0
$2.90M
Income Tax
$19.09K
$73.00K

Scores and fair valueIndustry

Altman Z-Score
50.04
0.23
Piotroski F-Score
4
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodEPRXS&P 500DifferenceEPRX per yearS&P 500 per year
1 month+22.0%-3.0%+25.0 pts
3 months+22.2%-2.8%+25.0 pts
Year to date+7.9%+11.5%−3.5 pts
1 year+28.5%+13.5%+15.1 pts
3 years+105.9%+77.7%+28.2 pts+27.2%+21.1%
5 years+262.2%+72.6%+189.6 pts+29.4%+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

6M EPRX shares were sold short on Oct 30, 2026, down 4.5% from the previous report, or 11.47% of the shares available to trade. At recent volumes it would take 10.4 days to buy them back. Over the last 20 sessions, 39.6% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20266,246,800-4.5%602,92910.4
Oct 15, 20266,538,961-3.8%1,246,0155.3
Sep 30, 20266,798,798-10.3%614,40811.1
Sep 15, 20267,582,355+6.6%673,95511.3
Aug 31, 20267,112,440+12.2%385,47118.4
Aug 14, 20266,336,985+4.9%220,31028.8
Jul 31, 20266,043,489+2.1%465,25913.0
Jul 15, 20265,921,701+8.4%230,01825.7
Jun 30, 20265,462,325+18.8%607,3489.0
Jun 15, 20264,597,670+12.7%282,50316.3
May 29, 20264,078,992+14.5%332,60012.3
May 15, 20263,561,791+15.8%149,95023.8

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?